RT Book, Section
A1 Mak, Raymond H.
A1 Baldini, Elizabeth H.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170411485
T1 Neoadjuvant and Adjuvant Radiotherapy for Non–Small-Cell Lung Cancer
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170411485
RD 2024/04/24
AB Radiation  therapy  (RT)  plays  an  important  role  in  the  management  of  locally  advanced  non–small-cell  lung  cancer  (NSCLC).  In  the  neoadjuvant  (preoperative)  setting,  thoracic  RT  with  concurrent  chemotherapy  (CT)  can  be  an  effective  means  for  downstaging  mediastinal  disease  and  improving  the  likelihood  of  complete  resection.  In  the  adjuvant  (postoperative)  setting,  RT  may  decrease  the  risk  of  locoregional  recurrence  for  patients  with  high-risk  disease  such  as  pathologic  N2  involvement  and/or  positive  margins.  Modern  techniques  of  radiation  treatment  planning  and  delivery  have  improved  the  safety  profile  and  efficacy  of  thoracic  RT.